About NextCure (NXTC)
NextCure, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Through its Functional, Integrat... Read more
- USD0.40
- USD0.45
- USD0.39
- USD1.82
- 16.80%
- --
- 512.37k
- 205.78k
- 12M
- 0.22
- -75.60%
Stock News
4 hours ago
Markets Weekly Outlook - U.S.-China Trade Talks & Global Economic Data
SeekingAlpha
4 hours ago
U.S. IPO Weekly Recap: Sizable Insurance IPOs Deliver Solid Trading
SeekingAlpha
yesterday
Trump Media reports narrower loss, sales gain in first quarter of Trump 2.0 era
MarketWatch
yesterday
5 industrial stocks ranked for their ability to perform in uncertain economic times
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
